Pharmacokinetics

Human observational studySupporting passage inspected

A small fasting single-dose study in eight healthy men given 4 g of a specific taurine product reported a plasma elimination half-life of 1.0 hour (range 0.7 to 1.4 hours), a peak plasma concentration of 86.1 mg/L at a median 1.5 hours, and an area under the curve of 206.3 mg-hr/L over 8 hours. That plasma result does not describe tissue stores, long-term effects, or prevention of stimulant-related injury.[1]

  • Very small (n=8), non-blinded, non-placebo-controlled pharmacokinetic study of one branded product; plasma and tissue kinetics are distinct.
  • Full-text-checked; no qualified clinical review.
Inspection history

Clinical review: not reviewed by a qualified clinician.

· Independent source inspection; applicability narrowed and inherited assertions excluded where unsupported. No qualified clinical review.

· Reopened and read the full open-access PMC text (upgraded from abstract-checked to full-text; an initial fetch attempt returned HTTP 429 and was retried). Added exact half-life range, Cmax and AUC, and identified the specific product manufacturer. Independent editorial review pending; no qualified clinical review.

What remains unresolved

Editorial assessment

These notes describe the scope of this review. Linked PMIDs are audit identifiers; an identifier alone does not verify a claim.

Narrowly supported passages published with study/product limits; remaining inherited assertions withheld from established-fact displays.

  • Not a comprehensive systematic review. Original monograph topics beyond the individual published claims—including monitoring schedules, contraindication lists, recovery assurances and detailed mechanisms—remain unverified.
  • No qualified clinician has reviewed these claims. Long-term outcomes and all marketed formulations have not been fully assessed.

This reference does not supply a dosing plan, monitoring timetable or recovery regimen. Discuss personal symptoms, medicines and laboratory results with a qualified clinician.

Explore the interaction evidence for this compound →

References

  1. Pharmacokinetics of oral taurine in healthy volunteers.

    Ghandforoush-Sattari M, Mashayekhi S, Krishna CV, Thompson JP, Routledge PA. J Amino Acids. 2010;2010:346237. 2010. PMID:22331997 · PMCID:PMC3275936 Full text inspected.

    Inspected location: PMC full text (open access): Materials and Methods (dosing, sampling schedule, product identity); Results (Cmax, Tmax, half-life, volume of distribution, AUC)

    Study context and inspection record

Source inspection and clinical review are separate. An abstract check is not a full-text review. The records above identify what was actually inspected and do not certify the complete literature.

Recorded verification attempts
  • Fresh PubMed EUtils retrieval for inherited lead PMID 22331997; identity, abstract and linked corrections checked where an abstract existed.
  • https://pubmed.ncbi.nlm.nih.gov/22331997/ — abstract; PubMed abstract: Methods: fasting healthy men; Results: single-dose plasma taurine elimination half-life

View this compound in the research library →

Related records in this class

Grouped under Ancillary compounds for navigation only. Shared class membership does not make findings, formulations or evidence interchangeable between records.

StackItSmart

Age confirmation

This reference discusses steroids, SARMs and other compounds. It is educational, not medical advice, and does not recommend using or combining them.

Your confirmation is saved in this browser when storage is available.